Do we know anything about how the money gets split between Boeing and PSID, other than the revs that PSID is claiming biowatch would be generated from reagents alone? Do we know for sure that Boeing does the maintenance, or do they just crank out the boxes?
Those attacking PSID for "giving" Boeing the manufacturing are short sighted and not considering all possibilities. Maybe PSID didn't have the facilities to produce the number of units needed. Maybe PSID knew they couldn't get the contract without Boeing. Maybe PSID sees Biowatch as only the first step, and once the US government is using these devices to protect their citizens, other countries will follow in short order (all PSID revenue).
There are plenty of options that don't end with, "Fire Caragol! He's an idiot."
The easy check trials are done THIS MONTH (http://clinicaltrials.gov/ct2/show/NCT01530347). IF the results come back with accuracy within accepted tolerance, the revenues would be staggering and would quickly become a reality.
There are no other devices on the market that can accurately check glucose without taking blood. I found discussion on a few others, but none I can find are in clinical trials.
The penny stock could/should become an absolute monster. This penny stock REALLY isn't like the others.